Consistently, our proteomic results showed the suppression of critical proteins in the PI3K-mediated AKT-pathway, such as PP2A, DUSP8, and ARID1A, which were simultaneously overexpressed in breast cancer cells treated with combined MPSE and IR. This evidence concerns the gene PIK3CA and breast carcinoma.